Guidance library · 62 questions

Who is responsible, and what inspectors find

Named leads, Responsible Persons, procedures and training, and the temperature findings that come up most often at MHRA and CQC inspections.

Reviewed by Jake Farrow, Managing DirectorLast reviewed 19 October 2026

This page explains who is answerable for temperature control in each setting, what procedures and training the guidance expects, and what MHRA and CQC inspectors have actually found. The one thing to remember is that tasks can be delegated but responsibility cannot: the named person must be able to show oversight of the checks other people do.

Why it matters

Unclear roles are where checks go missing

Temperature control rarely fails because nobody cares. It fails because everyone assumes someone else did the reading, or because the one person who knew how to reset the thermometer was on leave. The NHS England South West ICARS toolkit lists unclear roles and missed checks during staff absence among its avoidable cold chain breaches, which is why naming deputies and setting up cross-cover is part of the expectation rather than an extra.

Responsibility also decides who makes the hard call after an excursion. UKHSA's incident guidance says the provider where the breach happened decides whether vaccines can still be used, after specialist advice, and takes responsibility if they are used. A decision like that needs a named person and documented reasoning.

What the rules say

Wholesale: the Responsible Person

Regulation 43 of the Human Medicines Regulations 2012 requires a licence holder to have a quality system setting out responsibilities, processes and risk management. MHRA Guidance Note 6 sets out the Responsible Person's role: at least one year's practical experience of the licensed activities, the technical knowledge to understand storage conditions and temperature control, continuous contactability and UK residence. Regulation 45 requires every licence holder to have a Responsible Person with adequate knowledge and experience, whose functions include ensuring product quality is maintained in line with the marketing authorisations, and EU GDP 2.2 adds that the RP "may delegate duties but not responsibilities". GN6 also says 'Deputy RP' is not a legally recognised term, so the named RP carries legal responsibility for delegated tasks such as daily temperature checks, receives written reports on them and keeps records showing oversight.

The MHRA Inspectorate's mapping blog adds that the RP should be involved in mapping, supervise routine daily min/max monitoring and be consulted on any excursion. In Ireland the HPRA sets a different experience minimum; see the MHRA and HPRA comparison.

Practices, pharmacies, wards and care homes

Green Book chapter 3 asks for at least two named people, one from nursing and one from administration or management, responsible for ordering, receipt, cold chain recording, stock rotation and disposal. They may delegate monitoring, but only to staff who understand the whole process. CQC's GP mythbuster 17 repeats the two trained, designated staff and expects a cold chain policy covering delivery to administration, transport, breaches and shared learning.

NHS SPS says every organisation that stores medicines should have a local temperature control policy covering responsibility and accountability, monitoring, maintenance, excursions and contingency. It names the regulators: the GPhC for registered pharmacies, CQC for hospitals, GP practices and care homes, and the MHRA for specials and wholesale licence holders. For care homes, NICE SC1 asks for a process that covers storage temperatures and how they are monitored. The community pharmacy vaccination specification requires SOPs covering cold chain, escalation, record-keeping and training, reviewed regularly and after any significant incident.

Who holds responsibility, by setting
  1. Responsible PersonWholesale dealer
    • Legally responsible, including for delegated checks
    • Receives written reports on delegated duties
    • Supervises daily min/max monitoring
    • Consulted on every excursion
  2. Two named vaccine leadsGP practice
    • One from nursing, one from admin or management
    • Cold chain records, rotation and disposal
    • Delegates only to trained staff
  3. Set by local policyWards and clinical areas
    • Clear lines for checking, recording and reporting
    • Out-of-limit results reported to the right person
    • Medicines assessed before continued use
  4. Registered providerCare home
    • A process for storage temperatures and monitoring
    • Staff trained to read, reset and act
    • A route to escalate storage concerns

Drawn from GN6, the Green Book, CQC, NICE SC1 and the 2015 NHS Pharmaceutical QA Committee guidance.

What good looks like

Named, trained, covered and reviewed

Name the lead and a deputy in your procedure, and make sure both are trained and assessed as competent, as UKHSA expects of everyone who orders, stores or handles vaccines. Write a short SOP for the daily checks, alarms and excursions, and review it on a set cycle (Public Health Scotland suggests every two years) and after every significant incident.

Build oversight into the routine: the lead reviews and signs the records, and the review itself is recorded. The SW ICARS toolkit recommends a quarterly vaccine management review. If a third party monitors your fridges, remember the VMD's point that this does not transfer responsibility for responding to alerts.

Worked example

The vaccine lead goes on leave

This is an illustrative example. A practice's lead nurse for vaccines is away for two weeks. Before she goes, the administrative lead, the second named person, confirms that two healthcare assistants are trained to read, record, reset and react, and the rota names who reads the fridge each morning and who checks it was done.

On day six a reading is out of range. The assistant records it, quarantines the stock and calls the administrative lead, who follows the SOP and contacts the screening and immunisation team. When the nurse returns she reviews the fortnight's records, signs the review and adds the incident to the next quarterly review. Every step is written down, so the practice can show an inspector who did what.

Where it's unclear

Where the sources leave it to you

RP experience differs between the MHRA and the HPRA (one year or six months). No national source names a specific role on hospital wards: the 2015 NHS Pharmaceutical QA Committee guidance asks only for clear lines of responsibility, and SPS and the RPS leave it to local policy. Who checks at weekends is also left open (weekends and closed periods). Where the guidance is silent, assess the risk, name the person in your procedure and record your reasoning.

Inspection findings

What MHRA, CQC and GPhC inspectors have found

The MHRA GDP deficiency data for 2016, a sample of 148 of 1,428 inspections, cites major deficiencies including mapping that did not show where to place thermometers, cold chain deviations recorded but not put through CAPA, an RP who admitted fabricating readings to fill gaps, missing transport contracts, no audits of contract acceptors and 'customer collects' arrangements never formalised. GN6 gives storage of refrigerated products at ambient temperature as a possible critical deficiency. At manufacturers, the 2015 GMP deficiency examples include contractor mapping the company had not approved.

CQC publishes expectations rather than deficiency data: mythbuster 17 says inspectors may ask for the fridge log, maintenance checks and the breach policy, and may look in the fridge. PHE's Q&A on CQC inspection covers what to do when an inspector finds gaps in fridge records. GPhC inspection reports show the same pattern: one published in 2026 records standard 4.3 as not met because a pharmacy recorded temperatures for only one of its two fridges, and the unrecorded one showed an out-of-range maximum. See monitoring and alarms and records and data integrity for the detail behind these findings.

In summary

The short version

  • Name a lead and a deputy for temperature control, in writing.
  • In wholesale, the RP stays legally responsible for delegated checks and must show oversight.
  • Delegate only to staff trained to read, record, reset and react.
  • Keep a local temperature control policy and SOPs, reviewed regularly and after incidents.
  • Record your reviews, not just your readings.
  • Plan cover for leave, weekends and closures.
  • Expect inspectors to ask for the log, the maintenance records and the breach policy.

Responsibility and inspection

Questions, answered from the source

Last checked 19 October 2026. Each answer links to its source and says whether it is law, formal guidance or interpretation.

Does a supported living or Shared Lives service need its own medicines fridge?Interpretation

No. CQC says medicines should be stored in people's own homes rather than centrally, including medicines that need a fridge, and that supported living services do not need a separate medicines fridge or controlled drugs cupboard. Providers should work with each person to store medicines in a way that meets their needs and the manufacturer's requirements. CQC's Shared Lives page says the same for Shared Lives carers.

What's agreed, and what isn't

CQC does not say how temperature should be assured when refrigerated medicines sit in a person's domestic fridge. Providers usually handle this through the individual risk assessment and care plan.

Source
Managing medicines in supported living CQC, 20 February 2023
Status
Interpretation
Applies to
Care homes
Last checked
18 October 2026
Does CQC require care homes to monitor room temperature where medicines are stored, and what limit applies?Interpretation

Yes. CQC says policies and procedures must set out how staff will monitor the temperature of medicines storage areas, so that medicines are kept as the manufacturer recommends. Providers also need a way for staff to escalate storage concerns or seek advice. CQC suggests a medicines storage risk assessment that, as a minimum, considers the temperature requirements of the medicines, including those kept in residents' own rooms.

What's agreed, and what isn't

CQC's page gives no numeric room-temperature limit and no recording frequency. The commonly used 'below 25°C' comes from product labels and local ICB guidance, not from CQC. Rooms where residents self-administer are within scope, which is hard to monitor in practice; a risk assessment is the expected route.

Source
Storing medicines in care homes CQC, 3 November 2022
Status
Interpretation
Applies to
Care homes
Last checked
18 October 2026
Can we still give temperature-excursion vaccines under a PGD?Guidance

Yes. UKHSA says current medicines law does not prevent supplying risk-assessed, temperature-excursion vaccine under a PGD, and the PGD does not need amending. Where manufacturer advice or the risk assessment supports continued use, supply or administration can continue under the PGD without a Patient Specific Direction.

What's agreed, and what isn't

UKHSA bases this on NICE MPG2 recommendation 1.1.7 (off-label use under a PGD should be supported by best clinical practice). Local PGD governance may want the risk assessment recorded. Newer legal routes (for example the 2026 Vaccine Group Direction mentioned in UKHSA COVID guidance) are outside this 2022 text.

Status
Formal guidance
Applies to
GP practices, Community pharmacy
Last checked
18 October 2026
We have already given vaccines from a fridge that turned out to have failed. What now?Guidance

UKHSA says that if compromised vaccines have been given, the provider should consider forming an Incident Control Team (provider lead, SIT, HPT, communications and others). The team decides whether duty of candour requires telling patients and whether revaccination is needed, using UKHSA's revaccination tables.

What's agreed, and what isn't

The threshold for revaccination is different from the threshold for discarding stock: an incident that leads to disposal does not necessarily mean everyone needs revaccinating. For COVID-19 vaccines, UKHSA asks for incident-specific advice because its general guidance may not apply.

Status
Formal guidance
Applies to
GP practices, Community pharmacy
Last checked
18 October 2026
What are the 'four Rs' of vaccine fridge monitoring?Guidance

Read the thermometer's current, maximum and minimum temperatures every working day at the same time; Record them on a standard form and sign each entry; Reset the thermometer after each reading, and again once temperatures settle after busy periods; React if the temperature is outside +2°C to +8°C, and write down what you did.

What's agreed, and what isn't

The Green Book lets named staff delegate monitoring to others, but only if those staff understand the whole process. If nobody resets the thermometer, every later reading shows the old maximum, which makes an incident hard to investigate.

Status
Formal guidance
Applies to
GP practices, Community pharmacy, Care homes
Last checked
18 October 2026
What routine checks of vaccine stock and fridge records does guidance expect?Guidance

The 2014 protocol asks for weekly checks of fridge contents (rotation and expiry), monthly stock audits, and three-monthly audit records that can be shared with the local screening and immunisation team, plus a quarterly vaccine management review. The Green Book asks for stock records to be checked and updated at least monthly and includes a monthly review line on its sample temperature chart.

What's agreed, and what isn't

The 2014 PHE protocol has not been revised since; UKHSA still hosts it but it refers to NHS England screening and immunisation teams and older NPSA/HPA links. Scotland asks for an annual site audit; Northern Ireland asks for weekly data logger reviews and an annual audit.

Status
Formal guidance
Applies to
GP practices, Community pharmacy
Last checked
18 October 2026
Who decides whether we can still use vaccines after a cold chain breach?Guidance

The provider where the breach happened makes the decision, case by case, after a full risk assessment that includes specialist advice from the local HPT, the SIT and the vaccine manufacturer. If the vaccines are used, the prescriber or provider takes responsibility, so the advice and reasoning must be well documented.

What's agreed, and what isn't

Manufacturers can share in-house stability data but are not obliged to accept liability for use outside the licence. The Green Book (2013) also says using such vaccines is the user's responsibility. In Northern Ireland, HSC Trust Medicines Information supports the risk assessment, but responsibility stays with the GP practice.

Status
Formal guidance
Applies to
GP practices, Community pharmacy
Last checked
18 October 2026
Who do we report a vaccine fridge failure to in England?Guidance

Report all vaccine storage incidents to the local NHS England screening and immunisation team (SIT) first, and record them through local governance. If vaccines are wasted, complete an ImmForm stock incident record. Serious incidents follow the NHS England serious incident framework.

What's agreed, and what isn't

The 2022 guidance names 'NHSEI' and the Serious Incidents Framework; both have since changed names or been replaced (for example by PSIRF), so follow current local arrangements. Some regions now route advice through other services, such as South West ICARS. The 2014 protocol also says to report on ImmForm.

Status
Formal guidance
Applies to
GP practices, Community pharmacy
Last checked
18 October 2026
Who should be responsible for vaccine storage in a GP practice?Guidance

The Green Book says at least two named people should be nominated, one from the nursing team and one from administration or management, to be responsible for ordering, receipt and care of vaccines. They are responsible for cold chain recording, stock rotation and correct disposal, and can delegate temperature monitoring to trained staff.

What's agreed, and what isn't

UKHSA's incident guidance and Vaccine Update also expect everyone who orders, stores or handles vaccines to be trained and assessed as competent. Scotland uses a 'vaccine responsible person' plus a deputy and SOPs reviewed every two years; Northern Ireland uses a named 'Vaccine Controller'.

Status
Formal guidance
Applies to
GP practices
Last checked
18 October 2026
CQC found gaps in our vaccine fridge temperature records. Do we have to destroy the vaccines?Interpretation

No. PHE's Q&A says gaps or missing records do not on their own mean vaccines were stored badly. Do not dispose of vaccines or equipment; contact the local screening and immunisation team. Evidence such as stock inventories, delivery dates, stock turnover and the fridge's age, condition and service history can give reassurance.

What's agreed, and what isn't

This is a 2014 Q&A that refers to the withdrawn ImmForm helpsheet 18, but it matches the current 2022 UKHSA incident guidance (section 7.2: do not discard anything until discussed with the SIT/HPT). If there is real doubt, label the vaccines 'do not use' and quarantine the fridge while a risk assessment is done.

Status
Interpretation
Applies to
GP practices
Last checked
18 October 2026
At what point should ward staff quarantine medicines after an out-of-range reading?Guidance

The 2015 NHS Pharmaceutical QA Committee document gives example triggers. For fridges: quarantine if vaccines may have been frozen, or if contents may have been above 8 °C for more than half an hour where highly temperature-sensitive medicines are stored. For ambient areas: quarantine if the temperature exceeded the upper limit by more than 5 °C, or for more than a day. Out-of-limit results should always be reported to the appropriate person in the clinical area.

What's agreed, and what isn't

These are examples and differ from the current SPS position. SPS now says to quarantine with a "DO NOT USE" label at the start of every excursion assessment, and treats a single ambient excursion of less than 5 °C for under 7 days as unlikely to matter. Prefer the current SPS process where they differ.

Status
Formal guidance
Applies to
Hospitals and wards
Last checked
18 October 2026
Does the QP have to consider storage and transport temperatures before certifying a batch?Guidance

Yes. Annex 16, 1.5.3 says conditions of storage and transport for the batch, and for the sample if sent separately, should be taken into account by the QP before certification. For imported batches the QP should be satisfied that the finished product has been stored and transported under the required conditions (1.5.7). Section 3 allows certification after an unexpected deviation only where its impact is evaluated and shown to be negligible.

What's agreed, and what isn't

Section 3 does not mention temperature by name; MHRA's 2016 blog on unexpected deviations applies it to a transit excursion and warns that routinely using stability data to justify excursions would not be acceptable.

Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
For a general sale (GSL) wholesaler in Ireland, how should a temperature deviation be classified in our own deviation system?Guidance

The HPRA's model quality system for general sale wholesalers gives 'temperature deviations' as an example of a Major deviation (potential to compromise product quality) in the company's own classification scheme, alongside a Critical tier (e.g. failure to quarantine unsuitable product) and a Minor tier. Its temperature SOP template requires initial mapping or a documented RP-approved risk assessment, worst-case probe placement and daily max/min recording.

What's agreed, and what isn't

This is a company-level deviation classification example, not the HPRA's inspection grading. The guide says inspection frequency for these distributors is risk-based, between six months and five years.

Status
Formal guidance
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
If medicines are judged usable after an excursion but with a shorter shelf life, how should we label them?Guidance

SPS lists three possible outcomes: usable with a shortened shelf life, usable with extra patient monitoring, or not usable and discarded. If the medicine is usable, return it to correct storage, consider a sticker recording the excursion, and shorten the expiry date in line with local policy. Obscure the original expiry date but keep the batch number visible. Destroyed stock should be recorded in the stock control system, disposed of appropriately and reordered if needed.

What's agreed, and what isn't

Who can authorise a shortened expiry date is a matter for local policy. SPS suggests involving a stability expert, a clinician or a manager.

Source
Managing temperature excursions NHS SPS, 9 July 2024
Status
Formal guidance
Applies to
Hospitals and wards, Community pharmacy, GP practices
Last checked
18 October 2026
We sometimes cannot keep medicines within the labelled temperature, for example in an ambulance. What does RPS expect?Guidance

RPS says storage arrangements and monitoring should be based on risk, taking account of the medicines, how long they are stored and the room temperature. Storing or using a medicine outside the manufacturer's range requires a full risk assessment. There must be a policy and procedure for temperature excursions, with assurance that it is followed. If product integrity cannot be guaranteed, any decision to use the medicine must be fully risk assessed, and vaccines have their own guidance.

What's agreed, and what isn't

RPS sets the principle but not the method. The SPS excursion process and the NHS Pharmaceutical QA Committee clinical-area risk tools (Q10, MKT) are the usual way to carry it out.

Status
Formal guidance
Applies to
Hospitals and wards, GP practices, Care homes, Transport
Last checked
18 October 2026
Can a QP use stability data to certify a batch that had a temperature excursion during import shipping?Interpretation

Possibly, under the Annex 16 'unexpected deviation' route. The MHRA GMP blog gives an example: a product labelled 'store below 25°C' reached 29°C for three days in transit, and stability data showed no issue at 30°C for three months. This could be treated as an unexpected deviation if the shipment process was designed to meet the registered conditions. If shipment conditions were not controlled, routine use of stability data to justify excursions 'would not be acceptable'.

What's agreed, and what isn't

The deviation must be investigated, the root cause found and corrected, and impact shown to be negligible. Repeat occurrences no longer count as 'unexpected'. This route applies to QP certification by manufacturers and importers, not to wholesale RPs.

Source
Handling of unexpected deviations MHRA, 17 June 2016
Status
Interpretation
Applies to
Manufacturers
Last checked
18 October 2026
Is it acceptable to accept a load after an excursion if the stock is probably fine?Interpretation

The MHRA transport QRM blog says it is 'rare to find sound scientific justification' for accepting a load after an excursion. It notes that manufacturer stability information is often not directly comparable to the excursion. It says the most common reason for acceptance is commercial, which may put patients at risk and undermines risk management. The acceptable range is the product's labelled storage conditions.

What's agreed, and what isn't

This is inspector commentary, not a ban; release after an excursion remains possible with product-specific evidence from the marketing authorisation holder and an RP decision. The blog also says risk assessment 'should not be used' to justify an unsuitable practice (see also the 2020 COVID GDP blog).

Status
Interpretation
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
We moved racking and replaced a compressor in a qualified cold room. Do we need to requalify?Guidance

Annex 15 says changes should be assessed through change control for their impact on product quality, validation, calibration and maintenance, with a plan for any necessary verification or requalification (11.4), and the effectiveness of the change evaluated afterwards (11.7). Requalification at a fixed period must be justified, and gradual change over time should be considered (4.2).

What's agreed, and what isn't

Annex 15 does not list triggers. The HPRA temperature guide, which includes manufacturers in its scope, gives repair or replacement of the refrigeration unit, layout changes and set-point changes as re-mapping triggers, and the MHRA's 2015 GMP deficiency data cite a storage room reconfigured with no assessment of the effect on its mapping.

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
We're applying for a new WDA(H) - do we need mapping done before the inspection?Guidance

Yes. MHRA Guidance Note 6 says applicants must be inspection-ready at the point of application. That includes being able to show a temperature mapping exercise of the proposed wholesale area with a clear methodology, and evidence of transport validation. Applicants should also give details of ambient and cold chain storage, transport arrangements, computerised systems and business contingency plans.

What's agreed, and what isn't

GN6 does not define what counts as adequate transport validation. For small applicants using couriers, this usually means courier qualification plus packaging or lane qualification evidence. The MHRA mapping blog notes that new applicants are often unclear about mapping expectations.

Status
Formal guidance
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
How often should we re-map, and what is the RP's role?Interpretation

The MHRA blog says the risk assessment from mapping should define and justify how often future mapping is done, and should be reviewed regularly, for example during self-inspection. Mapping should be repeated for seasonal variation and if the storage area is reconfigured. The RP should be involved in the whole mapping process, aware of the findings and recommendations, supervise routine daily min/max monitoring, and be consulted on any temperature excursion.

What's agreed, and what isn't

No fixed re-mapping interval is set by EU GDP or this blog. Annual or summer/winter mapping is a common industry convention, not an MHRA rule. Be ready to justify whatever interval you choose.

Source
Temperature mapping - an introduction MHRA, 14 July 2016
Status
Interpretation
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
If a contractor carries out our temperature mapping, is their report enough?Interpretation

No; the company has to review and approve it. MHRA's 2015 GMP deficiency examples include mapping of production and warehouse areas by a contractor that "had not been approved by the company". Other findings were a retention sample store with no temperature logger nearby, a drug storage room reconfigured without assessing the impact on the existing mapping, and laboratory sample and standard storage areas with no temperature recording.

What's agreed, and what isn't

WHO Supplement 8 likewise says a protocol prepared by a third party should be authorised by the responsible person in the commissioning organisation. These are deficiency examples, not formal guidance.

Status
Interpretation
Applies to
Manufacturers, Laboratories
Last checked
18 October 2026
Is there a contractual requirement for GP practices to record vaccine fridge temperatures?Guidance

Yes, under the NHS England GP COVID-19 vaccination enhanced service for 2024–26, now expired; check the specification in force. It required every fridge storing vaccine to have a thermometer recording maximum and minimum temperatures. Readings had to be recorded "on all working days", with appropriate action when they are outside range. Fridges must also have enough space and airflow, with vaccine types separated.

What's agreed, and what isn't

This specification covered 1 September 2024 to 31 March 2026. Check the specification currently in force. The wording requires working days only, so weekend gaps are not a contract breach. They are still an excursion-detection risk that loggers are meant to cover.

Status
Formal guidance
Applies to
GP practices
Last checked
18 October 2026
What does the RCVS Practice Standards Scheme require for medicines temperature monitoring?Guidance

Core standard 10.1.6 (Small Animal) requires monitoring and recording of maximum and minimum temperatures wherever medicines are stored, including consulting rooms, prep rooms, fridges and vehicles. Where readings fall outside range, there must be evidence of an action plan to correct the deviation and deal with affected medicines, and practices should consider alarms. Without an alarm, and for min/max thermometers, checks must be made daily, and assessors will ask to see weekly written records. Temperature-sensitive medicines should ideally go out in vehicles only 'by use', in a cool box or fridge unit whose suitability is demonstrated.

What's agreed, and what isn't

Equivalent standards sit in the Farm Animal and Equine modules under different numbers. PSS is voluntary accreditation, but the underlying duty to store per the SPC is now law under VMR Schedule 3 paragraph 3E.

Status
Formal guidance
Applies to
Veterinary
Last checked
18 October 2026
What do MHRA GMP inspectors find wrong with alarms and humidity in manufacturing areas?Interpretation

MHRA's 2016 GMP deficiency examples include temperature alarms in manufacturing areas set at 18 °C to 26 °C when some materials and products required 2 °C to 25 °C; temperature and humidity captured only twice a day as spot readings with no max/min data; capsule shells not stored at the manufacturer's recommended 35 to 65% RH in the warehouse; a warehouse receiving area with no temperature monitoring against its 32 °C limit; and users permitted to change the default audit trail.

What's agreed, and what isn't

Examples from one year's dosage-form inspections, published to support self-inspection. They show the pattern: limits that do not match the product, readings that cannot show what happened between checks, and areas nobody thought to monitor.

Status
Interpretation
Applies to
Manufacturers
Last checked
19 October 2026
Can all our staff use one shared login for the temperature monitoring software?Guidance

No. MHRA says shared logins or generic user access should not be used for systems that generate, amend or store GXP data, and where a system supports individual accounts this must be used, even if it means buying extra licences. Companies must be able to show the access level given to each person, including historical access. System administrator access should be limited to as few people as possible, with unique credentials, and should not be given to people with a direct interest in the data (those generating, reviewing or approving it).

What's agreed, and what isn't

Where a system genuinely supports only one login, MHRA accepts equivalent control via third-party software or a version-controlled paper method, justified and documented, with increased data review. PIC/S PI 041-1 goes further and says shared passwords "even for reasons of financial savings, should be prohibited". Small sites may struggle with the segregation of admin rights, so document the rationale.

Status
Formal guidance
Applies to
All settings
Last checked
18 October 2026
Once our GMP temperature monitoring system is validated, do we need to do anything else to keep it validated?Guidance

Yes. EU GMP Annex 11 requires computerised systems to be periodically evaluated to confirm they remain valid, looking at things like deviations, incidents, upgrades, performance, security and validation status. Backups should be made regularly and restoration checked, stored data checked for accessibility and readability, and audit trails reviewed regularly. Changes, including configuration changes, must go through a defined change procedure, and it should be possible to get clear printed copies of stored data.

What's agreed, and what isn't

Annex 11 sets no fixed interval. The EMA Q&A says the period for re-evaluation should be based on the system's criticality. Annex 11 is EU GMP guidance that continues to be applied in UK GMP. A revised Annex 11 has been in draft, so check for updates.

Source
EudraLex Volume 4, Annex 11: Computerised Systems European Commission, January 2011
Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
18 October 2026
We are a small operation. How much data integrity control does the MHRA expect for our temperature records?Guidance

MHRA describes its guidance as a minimum expectation but asks for a risk-based approach where effort is "commensurate with the risk and impact" of a data integrity failure. Organisations are not expected to check data forensically as a routine, and a data integrity risk assessment is suggested to map processes and controls. Switching from electronic to paper, or back, does not remove the need for appropriate controls. The guidance encourages talking to the MHRA where your approach differs from what it describes.

What's agreed, and what isn't

The guidance does not cover medical devices. It is written for all MHRA-regulated GXP areas, so the examples are not always temperature-specific; you have to apply the principles to your own monitoring set-up. The MHRA Inspectorate blog (9 March 2018) confirmed the guide covers GDP as well as GMP and supersedes the March 2015 GMP-only guide.

Status
Formal guidance
Applies to
All settings
Last checked
18 October 2026
What should our documented review of temperature records actually include?Guidance

MHRA expects a procedure for reviewing and approving data, including a risk-based review of relevant metadata and audit trails. The review should be documented with a positive statement of whether or not issues were found, the date of the review and the reviewer's signature. A procedure should say what happens when an error or omission is found, with corrections that keep the original visible and traceable. Where you rely on summary reports from another organisation, such as a courier's or 3PL's temperature summary, MHRA says summaries are limited and you should assess the provider's data integrity controls first.

What's agreed, and what isn't

The guidance does not set how often reviews happen. WHO TRS 961 Annex 9 suggests reviewing temperature records monthly, with checks at least twice daily. UK sector guidance sets its own frequencies, so check those for your setting.

Status
Formal guidance
Applies to
All settings
Last checked
18 October 2026
What data integrity failures in temperature records have MHRA GDP inspectors found at wholesalers?Interpretation

MHRA's 2016 GDP deficiency data includes a Responsible Person who admitted adding fabricated readings to fill gaps in temperature records. Other findings were records made in pencil, unsigned temperature records and unapproved corrections. Equipment findings included a warehouse thermometer not calibrated across its operating range, an ambient-area thermometer installed so readings were not taken from the calibrated probe, uncalibrated equipment used to monitor transport, and mapping that did not establish where to place thermometers.

What's agreed, and what isn't

The report is published to support self-inspection. It shows that inspectors treat gaps and fabricated or unattributed entries as serious. A missed reading should be recorded and explained as a gap, never filled in afterwards.

Status
Interpretation
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
Does a haulier or courier holding medicines in transit in Ireland need a wholesale authorisation?Guidance

The HPRA's position is that storage of medicinal products for more than 48 hours during transportation, or any storage of refrigerated product regardless of time, is storage requiring that premises to hold a WDA. A carrier that does not own the product and only transports it generally does not need a WDA under the same conditions.

What's agreed, and what isn't

The wholesaling guide words the refrigerated case more softly ('may be regarded as falling within' WDA requirements), so for any cold-chain cross-dock arrangement it is worth confirming with the HPRA. Contracted transport should be audited and covered by a service level agreement that includes sub-contracting.

Status
Formal guidance
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
If we use a 3PL or courier, what do we need in place?Guidance

EU GDP chapter 7 requires a written contract that sets out each party's duties. The contract giver is responsible for the outsourced activity, must assess the contractor's competence, and should audit before work starts and whenever it changes, with audit frequency based on risk. The contractor must not subcontract without the contract giver's prior evaluation and approval. Chapter 9.2 adds that transport providers must be told the transport conditions for each consignment.

What's agreed, and what isn't

EU GDP 3.2 also says contracted premises should be covered by their own wholesale authorisation. The 2016 MHRA deficiency data included missing transport contracts, no audits of contract acceptors, and 3PLs allowed to subcontract without review.

Status
Formal guidance
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
Does a depot or freight site that holds our medicines overnight need to be on a wholesale licence?Interpretation

MHRA policy, set out in the inspector's blog, is that a site does not need to be named on a licence if ambient products are held there for less than 36 hours in transit and ownership has not transferred. Sites holding ambient products for more than 36 hours must be licensed. Sites holding refrigerated products must be licensed even for less than 36 hours, unless the products stay overnight in continuously refrigerated vehicles.

What's agreed, and what isn't

The policy only covers storage in transit; if picking, handling returns or decisions on resale happen there, the site must be on the licence. During COVID-19 the MHRA temporarily allowed up to 96 hours at a transit hub without a WDA(H), with a risk assessment. That was a temporary flexibility, not a change to this policy.

Status
Interpretation
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
If the customer collects the goods (ex-works), are we still responsible for transport temperature?Interpretation

Yes, according to the MHRA. The 2020 transport QRM blog says that although ex-works may suit the commercial terms, GDP makes the supplier responsible for delivering the medicine to the customer's delivery address. Using ex-works to step away from transport control is described as an abdication of responsibility that 'is not acceptable', and in one example it raised the supplier's inspection risk rating.

What's agreed, and what isn't

The 2016 MHRA deficiency data also cited 'customer collects' arrangements where GDP responsibilities had not been formalised. The practical answer is a written agreement defining who controls and monitors the journey, with the supplier keeping oversight.

Status
Interpretation
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
What transport temperature failings did MHRA inspectors cite in their deficiency data?Interpretation

The MHRA 2016 GDP deficiency data gives these transport examples. There was no sound assessment of whether ambient products needed temperature control across all transport routes, including third-party distributors. Uncontrolled ambient transport was used with no risk assessment. Transport temperature was monitored with uncalibrated equipment. Risk assessments contained erroneous assumptions about UK climate. Companies could not show ambient products stayed within limits for the whole journey. 'Customer collects' arrangements had not been formalised.

What's agreed, and what isn't

These were major deficiencies. They confirm that ambient products are in scope for transport temperature control, a point small wholesalers often miss.

Status
Interpretation
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
Brexit happened. Which version of the EU GMP Guide applies to a manufacturer in Great Britain?Law

Regulation C17 of the Human Medicines Regulations 2012 lets the MHRA publish its own GMP and GDP guidelines. Until it does, C17(3) says the guidelines published or adopted by the European Commission "as they applied immediately before IP completion day" (31 December 2020) continue to apply. The MHRA's 2020 note on EU guidance says Great Britain uses the versions as they stood at that date, while Northern Ireland uses the current EU versions.

What's agreed, and what isn't

Since 1 January 2025 C17 covers the whole UK (amended by the Windsor Framework regulations, SI 2024/832), and no later gov.uk page restates the GB and Northern Ireland split for GMP guidelines. In practice the MHRA still points manufacturers to EudraLex Volume 4 and the Orange Guide, which Pharmaceutical Press updated in 2026 for the revised Annex 19. Texts adopted after 2020, such as the 2022 Annex 1, are a point to confirm with your inspector if you rely on a GB-only reading.

Status
Law
Applies to
Manufacturers
Last checked
19 October 2026
Do the blood storage rules apply to a hospital blood bank, or only to blood establishments?Law

They apply to hospital blood banks too. Regulation 9 requires the person managing a hospital blood bank to keep a quality system that gives effect to the EDQM Good Practice Guidelines (reg 9(1)(b)), make sure storage, transport and distribution conditions meet Part 4 of the Schedule, and validate all Part 4 processes that apply to its activities. Documentation must be available for inspection, traceability data must be kept for at least 30 years, and serious adverse event records for at least 15 years.

What's agreed, and what isn't

Regulation 9 does not itself specify how storage must be monitored (continuous, alarms, mapping); that detail comes in through the EDQM Good Practice Guidelines the quality system must give effect to. MHRA inspectors apply those, GMP-style expectations and the Red Book in practice. The 30-year requirement covers traceability data, not necessarily raw temperature logs, so a local retention decision is needed for those. For blood bank refrigerator and freezer temperature charts, the RCPath and IBMS retention guidance (6th edition, October 2025, section 6.1.5) says 15 years; that is professional guidance, not law. The retention table on the records and data integrity page compares the periods.

Status
Law
Applies to
Blood, Hospitals and wards
Last checked
18 October 2026
What makes GMP a legal requirement for a manufacturer in Ireland?Law

The Medicinal Products (Control of Manufacture) Regulations 2007 (S.I. No. 539/2007), regulation 10(1), says a manufacturing authorisation holder must not manufacture medicinal products except in line with Schedule 2 and the principles and guidelines of GMP in the GMP Directive (Commission Directive 2003/94/EC). Schedule 2 requires premises, installations and equipment for handling, storage and distribution necessary to maintain product quality.

What's agreed, and what isn't

This is the regulation as made; later amendments implementing the EU's replacement GMP directive were not checked here. The HPRA inspects against the EU GMP Guide and grades deficiencies as critical, major or other, as the MHRA does.

Status
Law
Applies to
Manufacturers
Last checked
19 October 2026
Do we need a written temperature control policy, and what should it cover?Guidance

SPS says every organisation that stores or transports medicines should have a local temperature control policy, tailored to how many fridges, freezers and ambient areas it has and how critical the medicines are. The policy should cover responsibility and accountability for storage, choosing storage areas, setting up new fridges and freezers including the set point, monitoring and recording, routine maintenance, temperature during transport, handling excursions, and "contingency plans in the event of breakdown of temperature controls".

What's agreed, and what isn't

SPS does not name roles. It identifies the regulators as the GPhC for registered pharmacies, the CQC for hospitals, GP practices and care homes, and the MHRA for specials and wholesale licence holders.

Status
Formal guidance
Applies to
All settings
Last checked
18 October 2026
Does changing our insulated shipper or heating settings need formal change control in Ireland?Guidance

Yes, the HPRA GDP guide gives a change of insulated shipper for cold-chain products, a change to heating system settings and relocation of a storage area as examples of changes needing change control. Changes should be evaluated for impact on quality and traceability, including validation, and approved by relevant managers and the RP before implementation.

What's agreed, and what isn't

Such changes can also be mapping or qualification triggers under IA-G0011. The guide notes wholesalers working to other accredited standards should do a gap analysis against GDP.

Status
Formal guidance
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
Does the community pharmacy flu and COVID-19 vaccination service specify fridge requirements?Guidance

The 2026/27 NHS England advanced service specification requires the contractor to have SOPs for the service, including procedures to ensure cold chain integrity, with escalation, record-keeping and staff training covered. Vaccination must be done with appropriate cold chain management, including appropriate and timely action when temperatures deviate. Staff must follow the SOPs, which should be reviewed regularly and after any significant incident.

What's agreed, and what isn't

The specification does not set reading frequencies or equipment standards. It relies on the Green Book and on the pharmacy's own SOPs, so the detail sits in UKHSA guidance and GPhC inspection expectations.

Status
Formal guidance
Applies to
Community pharmacy
Last checked
18 October 2026
How does the HPRA grade GDP inspection findings, and where do temperature failures fit?Guidance

The HPRA uses Critical, Major and Other. Critical means a significant risk to patients or public health (example: activity increasing the risk of falsified medicines reaching patients). Major means a deviation resulting, or likely to result, in a product not complying with its authorisations, and HPRA names failure to comply with required storage and transport conditions as an example; combinations of related lower findings can be escalated.

What's agreed, and what isn't

The current HPRA inspections page gives no temperature example at Critical level. However, the HPRA's GDP Information Day slides (3 May 2022) listed 'storage of products requiring refrigeration at ambient temperatures' as an example of a possible Critical deficiency, the same example as MHRA Guidance Note 6. In practice a severe temperature failure could be graded Critical by either regulator.

Source
GDP inspections HPRA, undated
Status
Formal guidance
Applies to
Wholesalers (WDA), Transport
Last checked
18 October 2026
How much effort should go into the risk assessment behind our monitoring, mapping and calibration decisions?Guidance

ICH Q9(R1) says the effort, formality and documentation of quality risk management should be commensurate with the level of risk, and risk evaluation should be based on scientific knowledge and link to protecting the patient. Formality is not binary, and "resource constraints should not be used to justify the use of lower levels of formality". Its Annex II gives uses that fit monitoring directly: setting calibration and maintenance schedules, the extent of qualification, and the adequacy of storage and transport conditions.

What's agreed, and what isn't

Q9(R1) also asks for subjectivity to be managed and for decisions to rest on relevant data, so a requalification interval backed by trend data from continuous monitoring is easier to defend than one chosen by habit.

Status
Formal guidance
Applies to
Manufacturers, Laboratories, Wholesalers (WDA)
Last checked
19 October 2026
How often does the HPRA inspect wholesalers and what is published afterwards?Guidance

The HPRA wholesaling guide says routine inspections take place at least once every three years, more often for large wholesalers or those with poor compliance, and new wholesalers may be inspected about 12 to 18 months after the authorisation is granted. Inspection reports are sent within 15 days; routine and application inspections result in a GDP certificate or a 'statement of non-compliance with GDP', both published to EudraGMDP. The HPRA may refuse, suspend or revoke a WDA under S.I. No. 538 of 2007.

What's agreed, and what isn't

Published frequencies vary between HPRA documents: the GDP inspections web page says the first routine follow-up usually takes place 18 to 24 months after the initial (application) inspection, a different starting point from IA-G0008, and later ones are risk-based, and the general sale guide cites a six-month to five-year cycle. HPRA annual reports record 130 GDP inspections at wholesalers and distributors in 2024 and 128 in 2025. We found no HPRA publication of inspection reports; the HPRA's inspection material describes reports being issued to the company only.

Status
Formal guidance
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
How often does the Responsible Person have to review temperature records under HPRA guidance?Guidance

IA-G0011 repeatedly states that temperature records should be checked daily and independently reviewed (and, for ambient storage, approved) on a monthly basis by the Responsible Person, with a record of the review kept. Deviations outside limits should be notified promptly to the RP and investigations documented.

What's agreed, and what isn't

Where alarms notify staff audibly in real time and out of hours, the guide allows the frequency of checking monitoring records to be extended if the rationale is documented and justified. The EU GDP Guidelines do not specify a monthly RP review; this is HPRA-specific detail.

Status
Formal guidance
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
If our home care agency looks after a client's medicines, are we responsible for fridge storage?Guidance

NICE NG67 says responsibility for storing medicines usually stays with the person and their family or carers. Where a social care provider has agreed to take it on, recommendation 1.10.4 asks for sound processes, including seeking health professional advice on safe storage if needed, identifying the need for fridge storage, assessing the need for secure storage and reviewing storage needs. Recommendation 1.10.1 asks for a risk assessment of transport arrangements where the provider is involved.

What's agreed, and what isn't

NG67 sets no temperature monitoring requirement for people's homes. The 2015 NHS Pharmaceutical QA Committee guidance also excludes patients' own homes from its scope.

Status
Formal guidance
Applies to
Care homes
Last checked
18 October 2026
If we outsource mapping, calibration or monitoring, who is responsible when it goes wrong?Guidance

You are. ICH Q10, 2.7 says the pharmaceutical company is ultimately responsible for processes that assure control of outsourced activities, with a written agreement between contract giver and acceptor. Management review should include feedback on outsourced activities (4.1), and deviations go through CAPA with effort proportionate to risk (3.2.2).

What's agreed, and what isn't

MHRA's 2015 GMP deficiency examples include mapping by a contractor that the company had not approved. Approve the protocol before the study, review and approve the report, and audit the supplier. For a monitoring platform, Annex 11 asks for formal agreements with suppliers and service providers (clause 3).

Status
Formal guidance
Applies to
Manufacturers, Laboratories
Last checked
19 October 2026
We make or store investigational medicinal products. Which GMP rules apply in Great Britain and Northern Ireland?Guidance

Since the amended UK clinical trials regulations took effect on 28 April 2026, the MHRA says GMP for IMPs means the principles in Commission Directive 2003/94/EC for Great Britain and Commission Delegated Regulation 2017/1569 for Northern Ireland. The MHRA says separate GB guidelines for IMPs, intended to reflect the 2010 EU Annex 13, will be published in their own document.

What's agreed, and what isn't

Until that GB guide appears, the 2010 Annex 13 is the reference for GB: it asks the QP to verify conditions of storage and shipment (40) and for storage records at the original site to be reviewed before a transfer between trial sites (47). The MHRA page cites "Directive (EU) 2017/1559", which appears to be a typo.

Status
Formal guidance
Applies to
Manufacturers, Transport
Last checked
19 October 2026
What does NICE say care homes must have in place for medicines storage temperatures?Guidance

NICE SC1 recommendation 1.12.2 says a care home's process for storing medicines safely should include how and where medicines are stored, including fridge medicines and skin creams. It should also cover secure storage accessible only to authorised staff, and "the temperatures for storing medicines and how the storage conditions should be monitored". Recommendation 1.12.3 asks providers to assess each resident's storage needs.

What's agreed, and what isn't

NICE does not give temperature ranges, a check frequency, a fridge type or a retention period. It leaves these to the provider's process. Answers to 'do we need a dedicated medicines fridge?' or 'how often should we check the room?' therefore come from SPS, RPS, CQC or local ICB guidance, not NICE.

Source
Managing medicines in care homes (SC1) NICE, 14 March 2014
Status
Formal guidance
Applies to
Care homes
Last checked
18 October 2026
What experience does the HPRA expect of a Responsible Person, and can the RP be contracted?Guidance

The HPRA GDP guide treats evidence of six months' full-time direct GDP experience as a minimum, plus knowledge of the WDA conditions, the products and their storage needs, and the relevant law. A contract RP is allowed but needs a contract, must fulfil all RP duties under EU GDP 2.2, and time on site should be based on a documented risk assessment, with a record of time spent in the role.

What's agreed, and what isn't

Suitability is assessed case by case at application and on inspection, and part-time RPs must show they are contactable and present enough. This six-month minimum is HPRA-specific; the MHRA's comparable guidance sets one year's practical experience, so multi-country RPs should check each authority's text.

Status
Formal guidance
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
What is the Orange Guide, and is it different from the EU GMP Guide?Guidance

The Orange Guide is the MHRA's compilation "Rules and Guidance for Pharmaceutical Manufacturers and Distributors", published by Pharmaceutical Press. Its publisher describes it as the single source of European and UK guidance and UK legislation on the manufacture and distribution of medicines, including the EU GMP Guide as applied in the UK, the Qualified Person code of practice and guidance on investigational medicines. The Green Guide is the separate book for distributors (GDP).

What's agreed, and what isn't

It reproduces the EU GMP texts rather than replacing them, so the clauses you cite (for example Chapter 3, 3.19) are the same. The MHRA's GMP page lists the 2022 Orange and Green Guides; the Orange Guide is now sold as an online subscription and was updated in 2026 for Annex 19. The 2017 edition added an MHRA section on temperature control and monitoring.

Source
The MHRA Orange Guide (Pharmaceutical Press) MHRA, 24 September 2026
Status
Formal guidance
Applies to
Manufacturers
Last checked
19 October 2026
What temperature-control knowledge and availability does the MHRA expect from a wholesale RP?Guidance

MHRA Guidance Note 6 says the RP must have at least one year's practical experience of the licensed activities. They must have the technical knowledge to understand storage conditions and temperature control and how to transport medicines. The RP should be continuously contactable, resident in the UK, and should personally know the conditions needed for safe storage and distribution of the products traded. RP duties include approving returns to saleable stock and deciding the final disposition of returned or rejected products.

What's agreed, and what isn't

GN6 says the term 'Deputy RP' is not legally recognised; only the named RP carries legal responsibility, including for delegated tasks such as daily temperature checks. The RP must receive written reports on delegated duties and keep records showing oversight.

Status
Formal guidance
Applies to
Wholesalers (WDA)
Last checked
18 October 2026
Who in a GP practice is responsible for the vaccine fridge?Guidance

The SW ICARS toolkit, following Green Book chapter 3, says at least two people should be nominated, one from nursing and one from administration or management. They are responsible for ordering, receiving and looking after vaccines and for maintaining the cold chain. It also recommends a quarterly vaccine management review, at least weekly stock rotation checks, and orders every two to four weeks to avoid stockpiling.

What's agreed, and what isn't

The toolkit's list of avoidable breaches includes unclear roles and missed checks during staff absence. Naming deputies and setting up cross-cover is part of the expectation, not an optional extra.

Status
Formal guidance
Applies to
GP practices
Last checked
18 October 2026
Who should be responsible for checking ward temperatures and acting on out-of-range readings?Guidance

The 2015 NHS Pharmaceutical QA Committee document says there should be "clear lines of responsibility" for checking temperatures, recording results, reporting out-of-limit results, investigating them, and ensuring the affected medicines are assessed before anyone decides to keep using them. Its template fridge record has a space for who out-of-limit results should be reported to. It says out-of-limit results should always be reported to the appropriate person in the clinical area.

What's agreed, and what isn't

No national source in this set names a specific role, such as nurse in charge or ward pharmacist. SPS and RPS both leave it to local policy. The archived SPS 2020 COVID-19 vaccine fridge guide said checks could be delegated, but responsibility stayed with the clinical supervisor, who should review the log at least weekly.

Status
Formal guidance
Applies to
Hospitals and wards
Last checked
18 October 2026
Do the GPhC standards for registered pharmacies set a fridge temperature requirement?Interpretation

Not explicitly. Standard 4.3 says medicines and medical devices must be obtained from a reputable source, safe and fit for purpose, stored securely, safeguarded from unauthorised access, supplied safely and disposed of safely. There is no temperature wording. In practice, GPhC inspectors assess cold chain under 4.3. For example, a 2026 published improvement action plan recorded 4.3 as not met because a pharmacy recorded temperatures for only one of its two medicines fridges, and the unrecorded fridge showed an out-of-range maximum. The fixes included calibrated thermometers, daily recording for both fridges, and noting the reasons for anomalies.

What's agreed, and what isn't

The expectation of daily records and action on out-of-range readings comes from inspection practice and SPS/RPS guidance, not from the text of the standard. An individual action plan shows one inspector's finding and is not a GPhC policy statement.

Status
Interpretation
Applies to
Community pharmacy
Last checked
18 October 2026
How often do MHRA GMP inspectors actually cite storage temperature and calibration?Interpretation

In MHRA's published 2019 GMP deficiency data, covering 258 inspections and 1,648 deficiencies, Chapter 3, 3.19 (storage conditions provided, checked and monitored) was cited in 38 inspections and 3.41 (calibration) in 41. Annex 11 (computerised systems) was cited in 95 inspections and Annex 15 (qualification and validation) in 117. In the 2018 data (286 inspections) the figures were 49 for 3.19, 49 for 3.41, 87 for Annex 11 and 154 for Annex 15.

What's agreed, and what isn't

These are our counts from MHRA's spreadsheets, which record each EU GMP clause cited; one inspection can cite a clause more than once. Most 3.19 and 3.41 citations were graded Other, with some Majors and no Criticals. MHRA has published no GMP deficiency data after 2019. The 2019 summary ranks 3.41 eighth and 3.19 ninth among the most cited clauses in 2017.

Status
Interpretation
Applies to
Manufacturers
Last checked
19 October 2026
What cold chain evidence will a CQC inspector ask a GP practice for?Interpretation

Inspectors expect evidence that the cold chain is maintained from receipt of vaccines to administration, following the national (PHE, now UKHSA) recommendations. They may ask for the fridge temperature log, maintenance checks and a policy on what to do if a temperature breach occurs, and may look in the fridge. CQC says the cold chain policy should cover handling from delivery to administration, transport of vaccines outside the practice, actions after a breach and how learning from incidents is shared. At least two trained, designated staff should be responsible for ordering, receiving and caring for vaccines.

What's agreed, and what isn't

The mythbuster still names Public Health England, whose functions passed to UKHSA; the Green Book chapter 3 and the UKHSA protocol remain the reference documents.

Status
Interpretation
Applies to
GP practices
Last checked
18 October 2026
What temperature monitoring problems do MHRA GMP inspectors actually find at manufacturers?Interpretation

MHRA's 2016 GMP deficiency examples include: alarm limits wider than the product storage range; temperature and humidity captured only as twice-daily spot readings with no max/min data; no acceptance criteria for external calibration of warehouse probes; a receiving area not monitored against its limit; API shipped without temperature monitoring or control; and a standards fridge checked only weekly with no max/min readout. Import findings included no justification for not having a logger in every air-freight pallet, and procedures allowing mean kinetic temperature to assess excursions without investigating the cause.

What's agreed, and what isn't

These are examples from one year's dosage-form inspections, published to support self-inspection, not new requirements. More recent MHRA GMP deficiency datasets are summary-level and do not give comparable temperature examples.

Status
Interpretation
Applies to
Manufacturers, Laboratories
Last checked
18 October 2026
What temperature-related problems do MHRA GDP inspectors most often find?Interpretation

In the MHRA's published 2016 GDP deficiency data, a sample of 148 of 1,428 inspections, major findings under premises and equipment included the following. Mapping was not adequate to show the areas were suitable or to place thermometers at the extremes. Cold chain deviations were recorded but not put through CAPA. A warehouse thermometer had not been calibrated across its operating range. An ambient thermometer was installed so readings did not come from the calibrated probe. A fridge had ice build-up, read 0.6°C, and had unrecorded changes to its control dial.

What's agreed, and what isn't

This is the only GDP-specific deficiency report found on GOV.UK. The 2018 and 2019 deficiency files published on GOV.UK are GMP data, and later GDP data were not found. Patterns may have changed since 2016. The MHRA warns against focusing only on these deficiencies at the expense of risks specific to your business.

Status
Interpretation
Applies to
Wholesalers (WDA)
Last checked
18 October 2026

20-minute compliance check

How would you answer an inspector on temperature?

In 20 minutes we go through monitoring, alarms, mapping, calibration and excursions with you. You get the gaps in writing. No product tour.